WASHINGTON - Today, U.S. Senators Mike Bruan (R-Ind.) and Chris Coons (D-Del.), the co-chairs of the Senate ALS Caucus, applauded the National Institutes of Health (NIH) for their newly announced plans to invest $25 million over five years in a new program to spur innovative research on amyotrophic lateral sclerosis (ALS).
“As the co-chairs of the Senate ALS Caucus, we’ve seen firsthand how debilitating and devastating ALS is for patients and their families, but we’re also constantly reminded of the incredibly bravery, love, and determination that defines the ALS community. We are determined to do our part to help find innovative treatments for ALS, and this new research program through the NIH is a critical step toward advancing meaningful treatment options.”